mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.029 |
0.4 |